MDK and breast cancer: Although miR-1275 overexpression suppressed chemoresistance in BC cells, CCK-8 assays confirmed that the chemotherapeutic sensitivity of epirubicin evidently abrogated by MDK plasmid in BC cells (Fig. 5b, Supplementary Fig. 2c).